SET domain‐containing 2 histone lysine methyltransferase (SETD2/HIF‐1) and VEGF are abundantly activated in tumor sites, enhancing angiogenesis, which also induces MDSC migration to and differentiation at tumor sites.197, 198, 199. Here, SETD2 is linked to neoplasm.